Human Clinical Trials in Baltimore, Maryland
7 recruitingBaltimore, Maryland
Showing 1–7 of 7 trials
Recruiting
Phase 2
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Head and Neck CancerLaryngeal CancerOral Cavity Cancer+6 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins75 enrolled1 locationNCT07209189
Recruiting
Phase 1
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Human Papillomavirus-Related Carcinoma
National Cancer Institute (NCI)18 enrolled5 locationsNCT05985681
Recruiting
Not Applicable
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
Cervical CarcinomaHuman Papillomavirus Infection
National Cancer Institute (NCI)750 enrolled15 locationsNCT06498661
Recruiting
Not Applicable
Strategies to AchieVe Viral Suppression for Youth With HIV
Human Immunodeficiency Virus (HIV) Infection
Johns Hopkins University288 enrolled1 locationNCT06886971
Recruiting
Phase 1
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Human Papillomavirus Type 16Cervical Intraepithelial Neoplasia Grade IICervical Intraepithelial Neoplasia, Grade III
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins48 enrolled2 locationsNCT04131413
Recruiting
Phase 2
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Human Papilloma VirusAnal DysplasiaHIV
University of Maryland, Baltimore120 enrolled2 locationsNCT06624839
Recruiting
Phase 1
Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age
Human MetapneumovirusHuman Parainfluenza Virus Type 3
National Institute of Allergy and Infectious Diseases (NIAID)25 enrolled4 locationsNCT06546423